Adipose-specific disruption of signal transducer and activator of transcription 3 increases body weight and adiposity

Endocrinology

Volumn 149, Issue 4, 2008, Pages 1581-1590

  Cernkovich, Erin R ^a   Deng, Jianbei ^a   Bond, Michael C ^a   Combs, Terry P ^a   Harp, Joyce B ^a  

^a IL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; GLUCOSE; STAT3 PROTEIN; TRIACYLGLYCEROL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL DIFFERENTIATION; CELL HYPERPLASIA; CELL HYPERTROPHY; CELL SIZE; CONTROLLED STUDY; DNA RECOMBINATION; ENERGY EXPENDITURE; GENE; GLUCOSE TOLERANCE; HOMEOSTASIS; HYPERPHAGIA; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN ANALYSIS; STAT3 GENE;

ADIPOCYTES; ADIPOSITY; ANIMALS; BODY WEIGHT; EATING; ENERGY METABOLISM; FEMALE; LEPTIN; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRIGLYCERIDES;

EID: 41549123672     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-1148     Document Type: Article

References (54)

1. Popkin B, Doak C 1998 The obesity epidemic is a worldwide phenomenon. Nutr Rev 56:106-114
2. Hausman D, Digirolamo M, Bartness T, Hausman G, Martin R 2001 The biology of white adipocyte proliferation. Obes Rev 2:239-254
3. Rosen E, MacDougald O 2006 Adipocyte differentiation from the inside out. Nat Rev Mol Cell Biol 7:885-896
4. Stephens JM, Morrison RF, Pilch PF 1996 The expression and regulation of STATs during 3T3-L1 adipocyte differentiation. J Biol Chem 271:10441-10444
5. Deng J, Hua K, Lesser SS, Harp JB 2000 Activation of signal transducer and activator of transcription-3 during proliferative phases of 3T3-L1 adipogenesis. Endocrinology 141:2370-2376
6. Siegrist-Kaiser CA, Pauli V, Juge-Aubry CE Boss O, Pernina, Chin WW, Cusin I, Rohner-Heanrenaud F, Burger AG, Zapf J, Meier CA 1997 Direct effects of leptin on brown and white adipose tissue. J Clin Invest 100:2858-2864
7. Chen G, Koyama K, Yuan X, Lee Y, Zhou YT, O'Doherty R, Newgard CB, Unger RH 1996 Disappearance of body fat in normal rats induced by adenovirus-mediated leptin gene therapy. Proc Natl Acad Sci USA 93:14795-14799
8. Shimabukuro M, Koyama K, Chen G, Wang MY, Trieu F, Lee Y, Newgard CB, Unger RH 1997 Direct anti-diabetic effect of leptin through triglyceride depletion of tissues. Proc Natl Acad Sci USA 94:4637-4641
9. Fruhbeck G, Aguado M, Martinez JA 1997 In vitro lipolytic effect of leptin on mouse adipocytes: evidence for a possible autocrine/paracrine role of leptin. Biochem Biophys Res Commun 240:590-594
10. Fruhbeck G, Aguado M, Gomez-Ambrosi J, Martinez JA 1998 Lipolytic effect of in vivo leptin administration on adipocytes of lean and Ob/Ob mice, but not dB/dB mice. Biochem Biophys Res Commun 250:99-102
11. Wang M-Y, Lee Y, Unger RH 1999 Novel form of lipolysis induced by leptin. J Biol Chem 274:17541-17544
12. Bai Y, Zhang S, Kim KS, Lee JK, Kim KH 1996 Obese gene expression alters the ability of 30A5 preadipocytes to respond to lipogenic hormones. J Biol Chem 271:13939-13942
13. Zhou Y, Wang Z, Higa M, Newgard C, Unger R 1999 Reversing adipocyte differentiation: implications for treatment of obesity. Proc Natl Acad Sci USA 96:2391-2395
14. Path G, Bornstein SR, Gurniak M, Chrousos GP, Scherbaum WA, Hauner H 2001 Human breast adipocytes express interleukin-6 (IL-6) and its receptor system: increased IL-6 production by β-adrenergic activation and effects of IL-6 on adipocyte function. J Clin Endocrinol Metab 86:2281-2288
15. Trujillo ME, Sullivan S, Harten I, Schneider SH, Greenberg AS, Fried SK 2004 Interleukin-6 regulates human adipose tissue lipid metabolism and leptin production in vitro. J Clin Endocrinol Metab 89:5577-5582
16. Greenberg A, Nordan R, Mcintosh J, Calvo J, Scow R, Jablons D 1992 Interleukin 6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes: a possible role for interleukin 6 in cancer cachexia. Cancer Res 52:4113-4116
17. Van Hall G, Steensberg A, Sacchetti M, Fischer C, Keller C, Schjerling P, Hiscock N, Moller K, Saltin B, Febbraio MA, Pedersen BK 2003 Interleukin-6 stimulates lipolysis and fat oxidation in humans. J Clin Endocrinol Metab 88:3005-3010
18. Lyngso D, Simonsen L, Bulow J 2002 Metabolic effects of interleukin-6 in human splanchnic and adipose tissue. J Physiol (Lond) 543:379-386
19. Zvonic S, Cornelius P, Stewart WC, Mynatt RL, Stephens JM 2003 The regulation and activation of ciliary neurotrophic factor signaling proteins in adipocytes. J Biol Chem 278:2228-2235
20. Sleeman M, Anderson K, Lambert P, Yancopoulos G, Wiegand S 2000 The ciliary neurotrophic factor and its receptor, CNTFα. Pharm Acta Helv 74:265-272
21. Rodbell M 1964 Metabolism of isolated fat cells. I. Effects of hormones on glucose metabolism and lipolysis. J Biol Chem 239:375-380
22. Folch J, Lees M, Stanley GHS 1957 A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226:497-509
23. Zhong Z, Wen Z, Darnell JJ 1994 Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 264:95-98
24. Tontonoz P, Hu E, Graves R, Budavari A, Spiegelman B 1994 mPPARγ2: tissue-specific regulator of an adipocyte enhancer. Genes Dev 8:1224-1234
25. Soukas A, Socci ND, Saatkamp BD, Novelli S, Friedman JM 2001 Distinct transcriptional profiles of adipogenesis in vivo and in vitro. J Biol Chem 276:34167-34174
26. Tchoukalova YD, Sarr MG, Jensen MD 2004 Measuring committed preadipocytes in human adipose tissue from severely obese patients by using adipocyte fatty acid binding protein. Am J Physiol Regul Integr Comp Physiol 287:R1132-R1140
27. Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M, Mccullough AJ, Natale S, Forlani G, Melchionda N 2001 Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 50:1844-1850
28. Bugianesi E, Gastaldelli A, Vanni E, Gambino R, Cassader M, Baldi S, Ponti V, Pagano G, Ferrannini E, Rizzetto M 2005 Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. Diabetologia 48:634-642
29. Seppala-Lindroos A, Vehkavaara S, Hakkinen A-M, Goto T, Westerbacka J, Sovijarvi A, Halavaara J, Yki-Jarvinen H 2002 Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab 87:3023-3028
30. Bugianesi E, Pagotto U, Manini R, Vanni E, Gastaldelli A, De Lasio R, Gentilcore E, Natale S, Cassader M, Rizzetto M, Pasquali R, Marchesini G 2005 Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity. J Clin Endocrinol Metab 90:3498-3504
31. Hui J, Hodge A, Farrell G, Kench J, Kriketos A, George J 2004 Beyond insulin resistance in NASH: TNF-α or adiponectin? Hepatology 40:46-54
32. Wang J, Liu R, Hawkins M, Barzilai N, Rossetti L 1998 A nutrient-sensing pathway regulates leptin gene expression in muscle and fat. Nature 393:684-688
33. Wang M-Y, Orci L, Ravazzola M, Unger RH 2005 Fat storage in adipocytes requires inactivation of leptin's paracrine activity: implications for treatment of human obesity. Proc Natl Acad Sci USA 102:18011-18016
34. Gao Q, Wolfgang MJ, Neschen S, Morino K, Horvath TL, Shulman GI, Fu XY 2004 Disruption of neural signal transducer and activator of transcription 3 causes obesity, diabetes, infertility, and thermal dysregulation. Proc Natl Acad Sci USA 101:4661-4666
35. Cui Y, Huang L, Elefteriou F, Yang G, Shelton JM, Giles JE, Oz OK, Pourbahrami T, Lu CY, Richardson JA, Karsenty G, Li C 2004 Essential role of STAT3 in body weight and glucose homeostasis. Mol Cell Biol 24:258-269
36. Inoue H, Ogawa W, Ozaki M, Haga S, Matsumoto M, Furukawa K, Hashimoto N, Kido Y, Mori T, Sakaue H, Teshigawara K, Jin S, Iguchi H, Hiramatsu R, Leroith D, Takeda K, Akira S, Kasuga M 2004 Role of STAT-3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism in vivo. Nat Med10:168-174
37. Xu Aw, Ste-Marie L, Kaelin CB, Barsh GS 2007 Inactivation of signal transducer and activator of transcription 3 in proopiomelanocortin (POMC) neurons causes decreased POMC expression, mild obesity, and defects in compensatory refeeding. Endocrinology 148:72-80
38. Jones M, Thorburn A, Britt KL, Hewitt KN, Wreford NG, Proietto J, Oz OK, Leury BJ, Robertson KM, Yao S, Simpson ER 2000 Aromatase-deficient (ARKO) mice have a phenotype of increased adiposity. Proc Natl Acad Sci USA 97:2735-2740
39. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y 1999 Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257:79-83
40. Hu E, Liang P, Spiegelman BM 1996 AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 271:10697-10703
41. Friedman JM, Halaas JL 1998 Leptin and the regulation of body weight in mammals. Nature 395:763-770
42. Lin J, Arnold HB, Della-Fera MA, Azain MJ, Hartzell DL, Baile CA 2002 Myostatin knockout in mice increases myogenesis and decreases adipogenesis. Biochem Biophys Res Commun 291:701-706
43. He W, Barak Y, Hevener A, Olson P, Liao D, Le J, Nelson M, Ong E, Olefsky JM, Evans RM 2003 Adipose-specific peroxisome proliferator-activated receptor γ knockout causes insulin resistance in fat and liver but not in muscle. Proc Natl Acad Sci USA 100:15712-15717
44. Lee K, Villena J, Moon Y, Kim KH, Lee S, Kang C, Sul HS 2003 Inhibition of adipogenesis and development of glucose intolerance by soluble preadipocyte factor-1 (Pref-1). J Clin Invest 111:453-461
45. Gong DW, Bi S, Pratley RE, Weintraub BD 1996 Genomic structure and promoter analysis of the human obese gene. J Biol Chem 271:3971-3974
46. Fabris R, Nisoli E, Lombardi AM, Tonello C, Serra R, Granzotto M, Cusin I, Rohner-Jeanrenaud F, Federspil G, Carruba MO Vettor R 2001 Preferential channeling of energy fuels toward fat rather than muscle during high free fatty acid availability in rats. Diabetes 50:601-608
47. Xu A, Wang Y, Keshaw H, Xu L, Lam K, Cooper G 2003 The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. J Clin Invest 112:91-100
48. Villena JA, Viollet B, Andreelli F, Kahn A, Vaulont S, Sul HS 2004 Induced adiposity and adipocyte hypertrophy in mice lacking the AMP-activated protein kinase-α2 subunit. Diabetes 53:2242-2249
49. Franckhauser S, Munoz S, Pujol A, Casellas A, Riu E, Otaegui P, Su B, Bosch F 2002 Increased fatty acid re-esterification by PEPCK overexpression in adipose tissue leads to obesity without insulin resistance Diabetes 51:624-630
50. Chen HC, Stone SJ, Zhou P, Buhman KK, Farese Jr RV 2002 Dissociation of obesity and impaired glucose disposal in mice overexpressing acyl coenzyme A:diacylglycerol acyltransferase 1 in white adipose tissue. Diabetes 51:3189-3195
51. Hotamisligil G, Johnson R, Distel R, Ellis R, Papaioannou V, Spiegelman B 1996 Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein. Science 274:1377-1379
52. Dresner A, Laurent D, Marcucci M, Griffin ME, Dufour S, Cline GW, Slezak LA, Andersen DK, Hundal RS, Rothman DL, Petersen KF, Shulman GI 1999 Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J Clin Invest 103:253-259
53. Griffin M, Marcucci M, Cline G, Bell K, Barucci N, Lee D, Goodyear LJ, Kraegen EW, White MF, Shulman GI 1999 Free fatty acid-induced insulin resistance is associated with activation of protein kinase Cθ and alterations in the insulin signaling cascade. Diabetes 48:1270-1274
54. Randle P, Garland P, Hales C, Newsholme E 1963 The glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1:785-789